Gypenosides improve the intestinal microbiota of non-alcoholic fatty liver in mice and alleviate its progression

Gypenosides improve the intestinal microbiota of non-alcoholic fatty liver in mice and alleviate its progression

Gypenosides (GP) are a type of traditional Chinese medicine (TCM) extracted from plants and commonly applied for treatment of metabolic diseases. This study aims to explore the effects of GP extracts on alleviating non-alcoholic fatty liver disease (NAFLD). In this experiment, C57BL/6 J mice were ra...

Full description

Bibliographic Details
Main Authors: Xiaoqing Huang, Wenfan Chen, Changsheng Yan, Renzhi Yang, Qiongyun Chen, Hongzhi Xu, Yuanpeng Huang
Format: Article
Language:English
Published: Elsevier 2019-10-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Gypenosides
NAFLD
Lipid metabolism
Intestinal microbiota
Online Access:http://www.sciencedirect.com/science/article/pii/S075333221933015X

Internet

http://www.sciencedirect.com/science/article/pii/S075333221933015X

Similar Items